Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
Many nations are pursuing the rollout of SARS-CoV-2 vaccines as an exit strategy from
unprecedented COVID-19-related restrictions. However, the success of this strategy relies …
unprecedented COVID-19-related restrictions. However, the success of this strategy relies …
Emerging evidence on Omicron (B. 1.1. 529) SARS‐CoV‐2 variant
COVID's Omicron variant has sparked a slew of concerns across the globe. This review aims
to provide a brief overview of what we know about the Omicron variant right now. The new …
to provide a brief overview of what we know about the Omicron variant right now. The new …
Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double …
Background Early intramuscular administration of SARS-CoV-2-neutralising monoclonal
antibody combination, tixagevimab–cilgavimab, to non-hospitalised adults with mild to …
antibody combination, tixagevimab–cilgavimab, to non-hospitalised adults with mild to …
[HTML][HTML] Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million …
U Agrawal, S Bedston, C McCowan, J Oke, L Patterson… - The Lancet, 2022 - thelancet.com
Background Current UK vaccination policy is to offer future COVID-19 booster doses to
individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups …
individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups …
[HTML][HTML] Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections
Vaccination has proven effective against infection with SARS-CoV-2, as well as death and
hospitalisation following COVID-19 illness. However, little is known about the effect of …
hospitalisation following COVID-19 illness. However, little is known about the effect of …
Accelerated waning of the humoral response to COVID-19 vaccines in obesity
Obesity is associated with an increased risk of severe Coronavirus Disease 2019 (COVID-
19) infection and mortality. COVID-19 vaccines reduce the risk of serious COVID-19 …
19) infection and mortality. COVID-19 vaccines reduce the risk of serious COVID-19 …
COVID-19 vaccine strategies must focus on severe disease and global equity
In September, 2020, the WHO Prioritisation Roadmap for COVID-19 vaccines gave priority to
prevention of severe disease and the highest risk groups. In July, 2021, the revised …
prevention of severe disease and the highest risk groups. In July, 2021, the revised …
Metabolic disorders, COVID-19 and vaccine-breakthrough infections
N Stefan - Nature Reviews Endocrinology, 2022 - nature.com
Obesity and impaired metabolic health are important risk factors for severe COVID-19. Novel
data indicate that these risk factors might also promote vaccine-breakthrough SARS-CoV-2 …
data indicate that these risk factors might also promote vaccine-breakthrough SARS-CoV-2 …
Diabetes and COVID-19: short-and long-term consequences
C Steenblock, M Hassanein, EG Khan… - Hormone and …, 2022 - thieme-connect.com
When the corona pandemic commenced more than two years ago, it was quickly recognized
that people with metabolic diseases show an augmented risk of severe COVID-19 and an …
that people with metabolic diseases show an augmented risk of severe COVID-19 and an …
The protective effect of coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of COVID-19: a multicenter study from a large national health …
Abstract Background Coronavirus disease 2019 (COVID-19) vaccines have been proven to
decrease the severity of acute-phase infection; however, little is known about their effect on …
decrease the severity of acute-phase infection; however, little is known about their effect on …